Skip to Content

Semprex-D Dosage

Generic name: ACRIVASTINE 8mg, PSEUDOEPHEDRINE HYDROCHLORIDE 60mg
Dosage form: capsule

Medically reviewed on March 20, 2018.

The recommended dosage for adults and adolescents 12 years and older is one capsule administered orally, every 4 to 6 hours four times a day.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Semprex-D (acrivastine / pseudoephedrine)

Consumer resources

Professional resources

Semprex-D (FDA)

Related treatment guides

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

WADA Class Anti-Doping Classification

Manufacturer

Endo Pharmaceuticals Inc.

Drug Class

Upper respiratory combinations

Related Drugs

Allergic Rhinitis prednisone, Zyrtec, promethazine, fluticasone nasal, loratadine, cetirizine, triamcinolone nasal, montelukast, Flonase, Benadryl, Claritin, More...

Nasal Congestion epinephrine topical, sodium chloride nasal, pseudoephedrine, phenylephrine, Afrin, doxylamine, Loratadine-D 24 Hour, Sudafed Congestion, Claritin-D, oxymetazoline nasal, More...

Semprex-D Rating

2 User Reviews 10/10

Semprex-D Images

Pill Imprint MEDEVA SEMPREX-D (Semprex-D 8 mg-60 mg)

Semprex-D 8 mg-60 mg (MEDEVA SEMPREX-D)

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Nov 1st, 2018), Cerner Multum™ (updated Nov 1st, 2018), Wolters Kluwer™ (updated Oct 31st, 2018) and others. To view content sources and attributions, please refer to our editorial policy.